Rémi Tilmont
Impact in
-
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Multiple Myeloma Research and Treatments 7
- Oncology 7
- CAR-T cell therapy research 6
- Co-authors
- Holly Lee (8 shared papers)Ranjan Maity (8 shared papers)Paola Neri (8 shared papers)Sungwoo Ahn (7 shared papers)Elie Barakat (8 shared papers)Nizar J. Bahlis (8 shared papers)Noémie Leblay (7 shared papers)Mansour Poorebrahim (4 shared papers)
- Journals
- Blood (8 papers)iScience (1 paper)Annals of Pharmacotherapy (1 paper)Clinical Lymphoma Myeloma & Leukemia (1 paper)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Rémi Tilmont
10 papers receiving 68 citations
Peers
Comparison fields: 5 of 17
- Hematology 41
- Oncology 37
- Radiology, Nuclear Medicine and Imaging 20
- Molecular Biology 29
- Transplantation 1
Countries citing papers authored by Rémi Tilmont
This map shows the geographic impact of Rémi Tilmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémi Tilmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémi Tilmont more than expected).
Fields of papers citing papers by Rémi Tilmont
This network shows the impact of papers produced by Rémi Tilmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémi Tilmont. The network helps show where Rémi Tilmont may publish in the future.
Co-authors
The 25 scholars most cited alongside Rémi Tilmont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 17 | |
| 2 | 2022 | 11 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 8 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 0 |
About Rémi Tilmont
Rémi Tilmont is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 68 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), CAR-T cell therapy research (6 papers), Protein Degradation and Inhibitors (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Ubiquitin and proteasome pathways (1 paper), Immunotherapy and Immune Responses (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Hematology (41 citations), Oncology (37 citations), Radiology, Nuclear Medicine and Imaging (20 citations), Molecular Biology (29 citations) and Transplantation (1 citation). Rémi Tilmont has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Holly Lee, Ranjan Maity, Paola Neri, Sungwoo Ahn, Elie Barakat, Nizar J. Bahlis, Noémie Leblay, Mansour Poorebrahim, Ola Landgren and Bachisio Ziccheddu. Their work appears in journals such as Blood, iScience, Annals of Pharmacotherapy and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.